These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 1347738)

  • 1. Hypothalamic preprosomatostatin messenger ribonucleic acid expression in mice transgenic for excess or deficient endogenous growth hormone.
    Hurley DL; Phelps CJ
    Endocrinology; 1992 Apr; 130(4):1809-15. PubMed ID: 1347738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered growth hormone-releasing hormone mRNA expression in transgenic mice with excess or deficient endogenous growth hormone.
    Hurley DL; Phelps CJ
    Mol Cell Neurosci; 1993 Jun; 4(3):237-44. PubMed ID: 19912928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of hypothalamic growth hormone-releasing factor messenger ribonucleic acid by growth hormone and insulin-like growth factor I.
    Uchiyama T; Kaji H; Abe H; Chihara K
    Neuroendocrinology; 1994 May; 59(5):441-50. PubMed ID: 7912818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of food deprivation in the rat on hypothalamic expression of growth hormone-releasing factor and somatostatin.
    Bruno JF; Olchovsky D; White JD; Leidy JW; Song J; Berelowitz M
    Endocrinology; 1990 Nov; 127(5):2111-6. PubMed ID: 1977579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic dopaminergic neurons in transgenic dwarf mice: histofluorescence, immunocytochemical, and in situ hybridization studies.
    Phelps CJ; Carlson S; Hurley DL
    Anat Rec; 1991 Dec; 231(4):446-56. PubMed ID: 1686535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
    Tannenbaum GS; McCarthy GF; Zeitler P; Beaudet A
    Endocrinology; 1990 Nov; 127(5):2551-60. PubMed ID: 1977581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypophysiotropic somatostatin expression during postnatal development in growth hormone-deficient Ames dwarf mice: mRNA in situ hybridization.
    Hurley DL; Wee BE; Phelps CJ
    Neuroendocrinology; 1997 Feb; 65(2):98-106. PubMed ID: 9067987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autofeedback suppression of growth hormone (GH) secretion in transgenic mice expressing a human GH reporter targeted by tyrosine hydroxylase 5'-flanking sequences to the hypothalamus.
    Szabo M; Butz MR; Banerjee SA; Chikaraishi DM; Frohman LA
    Endocrinology; 1995 Sep; 136(9):4044-8. PubMed ID: 7649113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased hypothalamic somatostatin expression in mice transgenic for bovine or human GH.
    Hurley DL; Bartke A; Wagner TE; Wee BE; Phelps CJ
    J Neuroendocrinol; 1994 Oct; 6(5):539-48. PubMed ID: 7827624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of growth hormone-releasing hormone gene expression and secretion].
    Katakami H; Matsukura S
    Nihon Naibunpi Gakkai Zasshi; 1992 Oct; 68(10):1057-72. PubMed ID: 1360909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible role of hypothalamic somatostatin in the maintenance of rat pituitary responsiveness to growth hormone-releasing factor.
    Soya H; Suzuki M
    Endocrinology; 1990 Jan; 126(1):285-91. PubMed ID: 1967163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
    Park S; Peng XD; Frohman LA; Kineman RD
    Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis.
    Park S; Kamegai J; Johnson TA; Frohman LA; Kineman RD
    Endocrinology; 2000 Oct; 141(10):3556-63. PubMed ID: 11014208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion.
    Tannenbaum GS; Epelbaum J; Bowers CY
    Endocrinology; 2003 Mar; 144(3):967-74. PubMed ID: 12586774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of hypophysectomy and growth hormone administration on pre-prosomatostatin messenger ribonucleic acid in the periventricular nucleus of the rat hypothalamus.
    Rogers KV; Vician L; Steiner RA; Clifton DK
    Endocrinology; 1988 Feb; 122(2):586-91. PubMed ID: 2892665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deprivation of growth hormone-releasing hormone early in the rat's neonatal life permanently affects somatotropic function.
    Cella SG; Locatelli V; Mennini T; Zanini A; Bendotti C; Forloni GL; Fumagalli G; Arce VM; de Gennaro Colonna V; Wehrenberg WB
    Endocrinology; 1990 Oct; 127(4):1625-34. PubMed ID: 1976092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats.
    Sato M; Frohman LA
    Endocrinology; 1993 Aug; 133(2):793-9. PubMed ID: 8102097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypophysiotropic somatostatin expression during postnatal development in growth hormone-deficient Ames dwarf mice: peptide immunocytochemistry.
    Phelps CJ; Saleh MN; Romero MI
    Neuroendocrinology; 1996 Nov; 64(5):364-78. PubMed ID: 8930937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.